Completed NA INTERVENTIONAL 2-arm NCT04860661

Esketamine on Postpartum Depression in Cesarean Section Women (EKET)

Effect of Prophylactic Esketamine on Postpartum Depression in Cesarean Section: A Multicenter, Prospective, Randomized, Controlled Study

Sponsor: Ailin Luo

Conditions Esketamine Postpartum Depression

Interventions Esketamine Normal saline

Updated 6 times since 2021 Last updated: Aug 4, 2024 Started: May 1, 2021 Primary completion: Mar 31, 2024 Completion: Mar 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Esketamine and Postpartum Depression, this trial is completed. The trial is conducted by Ailin Luo and has accumulated 6 data snapshots since 2021. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA

Status: Recruiting → Completed
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2024 — Jul 2024 [monthly]

Recruiting NA
Aug 2023 — Jan 2024 [monthly]

Recruiting NA
May 2022 — Aug 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

May 2021 — May 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ailin Luo
Jingmen No.1 People's Hospital
Maternal and Child Health Hospital of Hubei Province

Data source: Tongji Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wuhan, China